Search Results
IDH Inhibitors for AML
IDH inhibitors for AML and MDS
Differentiation Syndrome and IDH Inhibitors in AML
IDH inhibitors for AML: highlights from ASH 2018
IDH inhibition in AML therapy
Dr. McCloskey Discusses IDH Inhibitors in AML
Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia
Updates on IDH inhibition in AML
The promising role of IDH inhibitors in AML
IDH inhibitors in AML
Targeted therapies in newly diagnosed AML: BCL2, FLT3 and IDH inhibitors
The impact of IDH mutations on the outcomes of patients with AML & inhibitors under investigation
